Learn About the HIP Breast Cancer Screening Trial
Main Findings
Major analyses of the primary trial endpoints were conducted at the 5, 7, and 18 year intervals from randomization and found that screening reduced mortality that was largely seen in the participants over the age of 50.
-
Proceedings: Changes in 5-year breast cancer mortality in a breast cancer screening program.
Shapiro S, Strax P, Venet L, Venet W
Proc Natl Cancer Conf. 1972; Volume 7: Pages 663-78 PUBMED -
Periodic screening for breast cancer: the HIP Randomized Controlled Trial. Health Insurance Plan.
Shapiro S
J. Natl. Cancer Inst. Monographs. 1997;: Pages 27-30 PUBMED -
Impact of efforts to increase participation in repetitive screenings for early breast cancer detection.
Fink R, Shapiro S, Roester R
Am J Public Health. 1972 Mar; Volume 62 (Issue 3): Pages 328-36 PUBMED -
Evidence on screening for breast cancer from a randomized trial.
Shapiro S
Cancer. 1977 Jun; Volume 39 (Issue 6 Suppl): Pages 2772-82 PUBMED -
The reluctant participant in a breast cancer screening program.
Fink R, Shapiro S, Lewison J
Public Health Rep. 1968 Jun; Volume 83 (Issue 6): Pages 479-90 PUBMED -
Periodic screening for breast cancer: the Health Insurance Plan Project, 1963 - 1986, and its sequelae.
Shapiro S, Venet W, Strax P, Venet L.